Dr. Brammer on Brentuximab Vedotin for Patients With T-Cell Lymphoma
October 26th 2017
Jonathan E. Brammer, MD, assistant professor of hematology, Ohio State University Comprehensive Cancer Center, discusses brentuximab vedotin (Adcetris) for patients with T-cell lymphoma.